Connect with us

Hi, what are you looking for?

State

Dailey stepping down as “Capitol Journal” host

Dailey has worked in news broadcasting in Alabama for the past 40 years.

APTV's Don Dailey hosts "Capitol Journal."

Don Dailey, the longtime host and executive director of Alabama Public Television’s “Capitol Journal,” which chronicles Alabama’s state legislature, announced on Tuesday that he’s stepping down. 

Dailey, who has been the “Capitol Journal” host since 2011, said in a release from APT that his final episode will be Dec. 11. APT also announced that Todd Stacy, publisher of Alabama Daily News and the former press secretary for Rep. Martha Roby, Gov. Bob Riley and Alabama House Speaker Mike Hubbard, will take over as host. 

“For the last decade, it has been a high point of my career to bring Alabamians important news from the Statehouse and the Capitol,” Dailey said in the APT release. “It has also been an honor and a privilege to interview leaders from all aspects of state government. I am so very thankful for the opportunities that have been afforded to me by Alabama Public Television and I look forward to the next chapter of my life.”

Dailey began his career in radio broadcasting while still in high school and worked for the next 30 years in radio around the state, primarily in Birmingham and Dothan, according to APT.

Josh Moon is an investigative reporter and columnist. You can reach him at [email protected].

Advertisement
Advertisement

More from APR

Local news

Records show rising revenue, recurring losses, a powerful DIP lender, and a reimbursement lawsuit shaping Jackson Hospital’s uncertain future ahead.

State

Mercedes-Benz will pay $149 million and provide consumer relief after states found the automaker used illegal emissions software in diesel vehicles.

Elections

Legislation seeking mandatory countywide and statewide general election audits was prefiled, requiring probate judges to oversee the auditing process.

Health

Oral semaglutide proved nearly as effective as the injectable version for treating obesity, delivering 13.7 percent average weight loss in a 64-week trial.